EC approves Pfizer's Herceptin biosimilar

31st July 2018 Uncategorised 0

Copycat of blockbuster breast cancer drug is Pfizer’s first oncology biosimilar

More: EC approves Pfizer's Herceptin biosimilar
Source: News